Als Hyperthyreose wird eine Krankheit mit zu starker Sekretion von Schilddrüsenhormon bezeichnet. Genetisch bedingte Hyperthyreosen können mit oder ohne Struma einhergehen.
1. |
Au KS et al. (1972) Thyrotoxic periodic paralysis. Periodic variation in the muscle calcium pump activity. |
2. |
Simmonds MJ et al. (2005) Regression mapping of association between the human leukocyte antigen region and Graves disease. |
3. |
Sutherland A et al. (2007) Genomic polymorphism at the interferon-induced helicase (IFIH1) locus contributes to Graves' disease susceptibility. |
4. |
Brand OJ et al. (2009) Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves' disease. |
5. |
None (1945) The hereditary and familial aspects of exophthalmic goitre and nodular goitre. |
8. |
Ryan DP et al. (2010) Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis. |
9. |
Kusakabe T et al. (1976) Thyrotoxic periodic paralysis: a peculiar case with unusual dystonic behavior and variable relations of paralysis to serum potassium levels. |
10. |
Ueda H et al. (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. |
11. |
Yeung RT et al. (1974) Thyrotoxic periodic paralysis. Effect of propranolol. |
12. |
Layzer RB et al. (1974) Periodic paralysis caused by abuse of thyroid hormone. |
13. |
Bernard JD et al. (1972) Thyrotoxic periodic paralysis in Californians of Mexican and Filipino ancestry. |
14. |
McFadzean AJ et al. (1967) Periodic paralysis complicating thyrotoxicosis in Chinese. |
15. |
Kilpatrick RE et al. (1994) Thyrotoxic hypokalemic periodic paralysis: report of four cases in black American males. |
16. |
Sternberg D et al. (2003) Lack of association of the potassium channel-associated peptide MiRP2-R83H variant with periodic paralysis. |
17. |
Jurkat-Rott K et al. (2004) Periodic paralysis mutation MiRP2-R83H in controls: Interpretations and general recommendation. |
18. |
None (2006) Clinical review: Thyrotoxic periodic paralysis: a diagnostic challenge. |
19. |
Kretowski A et al. (2003) Intercellular adhesion molecule 1 gene polymorphisms in Graves' disease. |
20. |
Kung AW et al. (2004) Association of novel single nucleotide polymorphisms in the calcium channel alpha 1 subunit gene (Ca(v)1.1) and thyrotoxic periodic paralysis. |
21. |
Chu X et al. (2011) A genome-wide association study identifies two new risk loci for Graves' disease. |
22. |
Pani MA et al. (2002) A polymorphism within the vitamin D-binding protein gene is associated with Graves' disease but not with Hashimoto's thyroiditis. |
23. |
Chen CR et al. (2003) The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim. |
24. |
Hiratani H et al. (2005) Multiple SNPs in intron 7 of thyrotropin receptor are associated with Graves' disease. |
25. |
Dechairo BM et al. (2005) Association of the TSHR gene with Graves' disease: the first disease specific locus. |
26. |
None (1985) Familial "hashitoxic' periodic paralysis. |
27. |
Akamizu T et al. (2003) Association study of autoimmune thyroid disease at 5q23-q33 in Japanese patients. |
28. |
Barbero P et al. (2004) Choanal atresia associated with prenatal methimazole exposure: three new patients. |
29. |
Ban Y et al. (2000) Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population. |
30. |
Vaidya B et al. (1999) The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus. |
31. |
Chen QY et al. (1999) HLA-DRB1*08, DRB1*03/DRB3*0101, and DRB3*0202 are susceptibility genes for Graves' disease in North American Caucasians, whereas DRB1*07 is protective. |
32. |
Chen QY et al. (2000) The human leukocyte antigen HLA DRB3*020/DQA1*0501 haplotype is associated with Graves' disease in African Americans. |
34. |
Hermenegildo C et al. (2002) Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in hyperthyroid patients. |
35. |
Robertson DM et al. (2003) Retinal microvascular abnormalities in patients treated with external radiation for graves ophthalmopathy. |
36. |
MARTIN L et al. (1951) The hereditary and familial aspects of toxic nodular goitre (secondary thyrotoxicosis). |
37. |
Wikipedia Artikel Wikipedia DE (Hyperthyreose) |